Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

Peptide–drug conjugates (PDCs) are the next generation of targeted therapeutics drug after antibody–drug conjugates (ADCs), with the core benefits of enhanced cellular permeability and improved drug selectivity. Two drugs are now approved for market by US Food and Drug Administration (FDA), and in t...

Full description

Bibliographic Details

Published in:	Acta Pharmaceutica Sinica B
Main Authors:	Chen Fu, Lifeng Yu, Yuxi Miao, Xinli Liu, Zhaojin Yu, Minjie Wei
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Subjects:	Peptide Drug Linker Targeted therapy Stability Permeability
Online Access:	http://www.sciencedirect.com/science/article/pii/S221138352200332X